Table 3 Association of IITQ Measures with Participant Characteristics at Baseline
Treatment Outcome | Diabetes Worries | Perceptions of Insulin Therapy | Treatment Satisfaction | Treatment Preference |
|---|---|---|---|---|
Gender (Male = 1) | -.08/-.05 | -.00/.08* | .03/.06 | -.01/.01 |
Race (Caucasian = 1) | -.18***/-.10* | .04/.02 | .08/.03 | .03/.07 |
Age (Years) | -.03/-.04 | -.04/.09* | .03/.12** | -.02/.06 |
Duration of Diabetes (Years) | -.05/03 | .01/.05 | .02/.03 | .07/.08 |
Weight (Kilograms) | -.16***/-.16 *** | -.06/-.05 | -.00/-.09* | -.05/-.11** |
BMI (kg/m2) | -.11*/-.09* | -.05/-.07 | -.01/-.09* | -.05/-.12** |
A1c (%) | .00/.01 | -.03/-.06 | -.14**/-.11** | -.01/-.07 |
SF-36 PCS | -.07/.02 | .13**/.14*** | .04/.09* | .00/.08 |
SF-36 MCS | -.09/-.12** | .15***/.17*** | .08/-.01 | .11*/.01 |